{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:59:13Z","timestamp":1793915953642,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clinthera.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T09:15:57Z","timestamp":1625735757000},"page":"1371-1380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Tegoprazan"],"prefix":"10.1016","volume":"43","author":[{"given":"Sungpil","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Youn","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongtae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun Seog","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Seok","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyun-Seop","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.06.007_bib0001","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0002","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bpg.2013.06.005","article-title":"Management of the patient with incomplete response to PPI therapy","volume":"27","author":"Kahrilas","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9459(24)07758-1","article-title":"The chemically elegant proton pump inhibitors","volume":"70","author":"Roche","year":"2006","journal-title":"Am J Pharm Educ"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0004","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","article-title":"Pharmacology of proton pump inhibitors","volume":"10","author":"Shin","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 Years of Proton Pump Inhibitors: A Comprehensive Review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0006","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1046\/j.1365-2036.2000.00829.x","article-title":"Proton pump inhibitors: better acid suppression when taken before a meal than without a meal","volume":"14","author":"Hatlebakk","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0007","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2036.2009.03979.x","article-title":"Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor\u2013evidence for dosing flexibility","volume":"29","author":"Lee","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0008","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2125.2007.02889.x","article-title":"Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole","volume":"64","author":"Sostek","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0009","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5056\/jnm18029","article-title":"Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases","volume":"24","author":"Oshima","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/1756283X17745776","article-title":"Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date","volume":"11","author":"Sugano","year":"2018","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0011","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/apt.15438","article-title":"Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ-12420), a novel potassium-competitive acid blocker, in healthy male subjects","volume":"50","author":"Han","year":"2019","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0012","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/apt.15480","article-title":"Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block","volume":"50","author":"Scarpignato","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/jpet.117.244202","article-title":"Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility","volume":"364","author":"Takahashi","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0014","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF03259193","article-title":"Bioavailability of Omeprazole as Enteric Coated (EC) Granules in Conjunction with Food on the First and Seventh Days of Treatment","volume":"2","author":"Andersson","year":"2012","journal-title":"Drug Investig"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00044011-199509020-00002","article-title":"Decreased Oral Bioavailability of Lansoprazole in Healthy Volunteers when Given with a Standardised Breakfast","volume":"9","author":"Bergstrand","year":"1995","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0016","first-page":"315","article-title":"The effect of food and antacids on lansoprazole absorption and disposition","author":"Delhotal-Landes","year":"1991","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/j.1875-9114.1997.tb03675.x","article-title":"Proton pump inhibitors and acid-related diseases","volume":"17","author":"Sachs","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0018","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1365-2036.2006.02911.x","article-title":"Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease","volume":"23","author":"Gunaratnam","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0019","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2036.2000.00768.x","article-title":"Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors","volume":"14","author":"Laine","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0020","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2036.2009.03976.x","article-title":"Review article: Strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause","volume":"29","author":"Murugesan","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0021","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1007\/s10620-006-9419-3","article-title":"Chronic hypergastrinemia: causes and consequences","volume":"52","author":"Orlando","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0022","series-title":"The physiology of gastric storage and emptying. U: Leonard R, ur. Physiology of the gastrointestinal tract","author":"Mayer","year":"1994"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0023","series-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Goodman","year":"1996"},{"key":"10.1016\/j.clinthera.2021.06.007_bib0024","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00228-018-2502-9","article-title":"Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects","volume":"74","author":"Kim","year":"2018","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182100237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182100237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:54:43Z","timestamp":1758963283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929182100237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S014929182100237X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.06.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Tegoprazan","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}